chr11-1255193-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002458.3(MUC5B):​c.15817G>C​(p.Ala5273Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0296 in 1,487,052 control chromosomes in the GnomAD database, including 826 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.029 ( 63 hom., cov: 31)
Exomes 𝑓: 0.030 ( 763 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.39

Publications

8 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B Gene-Disease associations (from GenCC):
  • interstitial lung disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002364099).
BP6
Variant 11-1255193-G-C is Benign according to our data. Variant chr11-1255193-G-C is described in ClinVar as Benign. ClinVar VariationId is 164005.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0286 (3594/125626) while in subpopulation NFE AF = 0.0359 (2159/60164). AF 95% confidence interval is 0.0346. There are 63 homozygotes in GnomAd4. There are 1759 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 63 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002458.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUC5B
NM_002458.3
MANE Select
c.15817G>Cp.Ala5273Pro
missense
Exon 36 of 49NP_002449.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUC5B
ENST00000529681.5
TSL:5 MANE Select
c.15817G>Cp.Ala5273Pro
missense
Exon 36 of 49ENSP00000436812.1

Frequencies

GnomAD3 genomes
AF:
0.0286
AC:
3595
AN:
125572
Hom.:
63
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0157
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00983
Gnomad ASJ
AF:
0.0301
Gnomad EAS
AF:
0.000220
Gnomad SAS
AF:
0.00808
Gnomad FIN
AF:
0.0859
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0359
Gnomad OTH
AF:
0.0268
GnomAD2 exomes
AF:
0.0242
AC:
3670
AN:
151624
AF XY:
0.0238
show subpopulations
Gnomad AFR exome
AF:
0.0137
Gnomad AMR exome
AF:
0.00526
Gnomad ASJ exome
AF:
0.0273
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0716
Gnomad NFE exome
AF:
0.0307
Gnomad OTH exome
AF:
0.0229
GnomAD4 exome
AF:
0.0297
AC:
40417
AN:
1361426
Hom.:
763
Cov.:
35
AF XY:
0.0290
AC XY:
19517
AN XY:
671894
show subpopulations
African (AFR)
AF:
0.0116
AC:
361
AN:
31086
American (AMR)
AF:
0.00600
AC:
211
AN:
35176
Ashkenazi Jewish (ASJ)
AF:
0.0291
AC:
715
AN:
24546
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35082
South Asian (SAS)
AF:
0.00984
AC:
763
AN:
77516
European-Finnish (FIN)
AF:
0.0745
AC:
3423
AN:
45948
Middle Eastern (MID)
AF:
0.00461
AC:
24
AN:
5202
European-Non Finnish (NFE)
AF:
0.0318
AC:
33451
AN:
1050554
Other (OTH)
AF:
0.0261
AC:
1469
AN:
56316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.416
Heterozygous variant carriers
0
1777
3555
5332
7110
8887
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1236
2472
3708
4944
6180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0286
AC:
3594
AN:
125626
Hom.:
63
Cov.:
31
AF XY:
0.0291
AC XY:
1759
AN XY:
60384
show subpopulations
African (AFR)
AF:
0.0156
AC:
503
AN:
32234
American (AMR)
AF:
0.00982
AC:
110
AN:
11204
Ashkenazi Jewish (ASJ)
AF:
0.0301
AC:
94
AN:
3120
East Asian (EAS)
AF:
0.000221
AC:
1
AN:
4524
South Asian (SAS)
AF:
0.00810
AC:
33
AN:
4072
European-Finnish (FIN)
AF:
0.0859
AC:
650
AN:
7566
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
276
European-Non Finnish (NFE)
AF:
0.0359
AC:
2159
AN:
60164
Other (OTH)
AF:
0.0266
AC:
44
AN:
1656
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
162
324
486
648
810
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0252
Hom.:
20
TwinsUK
AF:
0.0299
AC:
111
ALSPAC
AF:
0.0330
AC:
127
ExAC
AF:
0.00670
AC:
704

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ala5273Pro in exon 36 of MUC5B: This variant is not expected to have clinical si gnificance because it has been identified in 8.1% (15/186) of Finnish chromosome s from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm.nih.g ov/projects/SNP; dbSNP rs56123928).

May 22, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.050
BayesDel_addAF
Benign
-0.73
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.012
DANN
Benign
0.22
DEOGEN2
Benign
0.014
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.00022
N
LIST_S2
Benign
0.17
T
MetaRNN
Benign
0.0024
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-0.83
N
PhyloP100
-1.4
PrimateAI
Benign
0.34
T
PROVEAN
Benign
0.24
N
REVEL
Benign
0.0050
Sift
Benign
0.30
T
Vest4
0.068
ClinPred
0.00054
T
GERP RS
-2.8
Varity_R
0.040
gMVP
0.24
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56123928; hg19: chr11-1276423; API